Metal–Metalloid\nModified C<sub>36</sub> Fullerene:\nA Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine\nExplored through DFT and MD Simulations

Spurred by the latest developments and growing utilization\nof zero-dimensional\n(0D) drug delivery and drug sensors, this investigation examines the\npossibilities of the 0D C<sub>36</sub> fullerene for drug delivery\nand the detection of the anticancer drug chlormethine (CHL), the overabundance\nof which poses a significant threat to living organisms. This study\nemploys density functional theory and ab initio molecular dynamics\n(AIMD) simulations (AIMD) to evaluate and gain insights into the interaction\nmechanisms between pristine C<sub>36</sub> fullerene, metal–metalloid\n(MM)-modified C<sub>36</sub> fullerene (with Al, Fe, and B), and the\nanticancer drug CHL. It is observed that in the gas phase, the CHL\ndrug molecule adsorbs onto the fullerenes in the following order:\nB–C<sub>36</sub> > Fe–C<sub>36</sub> > Al–C<sub>36</sub> > C<sub>36</sub>. However, when considering the solvent\neffect, the adsorption energy of the CHL drug molecule on B–C<sub>36</sub> increases, indicating chemisorption behavior. This implies\nthat B–C<sub>36</sub> could be a promising candidate for drug\ndelivery applications, particularly for the CHL anticancer drug. In\ncontrast, the adsorption energy of the CHL drug molecule on Fe–C<sub>36</sub> decreases with the presence of the solvent, resulting in\nintermediate physisorption. Due to its minimal recovery time, excellent\nsensing response, intermediate physisorption, and shorter interatomic\ndistance compared to C<sub>36</sub> and Al–C<sub>36</sub> fullerenes,\nFe–C<sub>36</sub> is well-suited as a drug sensor for CHL.\nAIMD simulations demonstrate that the B–C<sub>36</sub>/CHL\nand Fe–C<sub>36</sub>/CHL complexes are well-equilibrated and\nhighly stable in the aqueous phase at 300 and 310 K respectively,\nwith no evidence of bond breakage or formation. The structural stability\nobserved, even with temperature fluctuations, indicates that the electrostatic\ninteractions are robust enough to maintain cohesion of the fragments.

Publication Details

Journal
Figshare
Published
2024-12-02
DOI
https://doi.org/10.1021/acsomega.4c08490.s001
Primary Topic
Boron and Carbon Nanomaterials Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metal–Metalloid\nModified C36 Fullerene:\nA Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine\nExplored through DFT and MD Simulations

Figshare
Boron and Carbon Nanomaterials Research
article

Metal–Metalloid\nModified C36 Fullerene:\nA Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine\nExplored through DFT and MD Simulations

article en

Abstract

Spurred by the latest developments and growing utilization\nof zero-dimensional\n(0D) drug delivery and drug sensors, this investigation examines the\npossibilities of the 0D C<sub>36</sub> fullerene for drug delivery\nand the detection of the anticancer drug chlormethine (CHL), the overabundance\nof which poses a significant threat to living organisms. This study\nemploys density functional theory and ab initio molecular dynamics\n(AIMD) simulations (AIMD) to evaluate and gain insights into the interaction\nmechanisms between pristine C<sub>36</sub> fullerene, metal–metalloid\n(MM)-modified C<sub>36</sub> fullerene (with Al, Fe, and B), and the\nanticancer drug CHL. It is observed that in the gas phase, the CHL\ndrug molecule adsorbs onto the fullerenes in the following order:\nB–C<sub>36</sub> > Fe–C<sub>36</sub> > Al–C<sub>36</sub> > C<sub>36</sub>. However, when considering the solvent\neffect, the adsorption energy of the CHL drug molecule on B–C<sub>36</sub> increases, indicating chemisorption behavior. This implies\nthat B–C<sub>36</sub> could be a promising candidate for drug\ndelivery applications, particularly for the CHL anticancer drug. In\ncontrast, the adsorption energy of the CHL drug molecule on Fe–C<sub>36</sub> decreases with the presence of the solvent, resulting in\nintermediate physisorption. Due to its minimal recovery time, excellent\nsensing response, intermediate physisorption, and shorter interatomic\ndistance compared to C<sub>36</sub> and Al–C<sub>36</sub> fullerenes,\nFe–C<sub>36</sub> is well-suited as a drug sensor for CHL.\nAIMD simulations demonstrate that the B–C<sub>36</sub>/CHL\nand Fe–C<sub>36</sub>/CHL complexes are well-equilibrated and\nhighly stable in the aqueous phase at 300 and 310 K respectively,\nwith no evidence of bond breakage or formation. The structural stability\nobserved, even with temperature fluctuations, indicates that the electrostatic\ninteractions are robust enough to maintain cohesion of the fragments.

Figshare
Openalex Percentile: Top 75%
Boron and Carbon Nanomaterials Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metal–Metalloid\nModified C<sub>36</sub> Fullerene:\nA Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine\nExplored through DFT and MD Simulations · Figshare (2024) | TGRS Research Map | TGRS